9th Vaccine & ISV Congress

18-20 October 2015 | Lotte Hotel, Seoul, South Korea

Abstract submission deadline 15 May 2015. Submit your abstract here »

The aim of the 9th Vaccine & ISV Congress is to provide a forum for researchers, professionals and policy makers to present, share and exchange the latest cutting edge discoveries in vaccines and vaccinations. We hope to facilitate new collaborations between experts in the field and inspire new and innovative ideas in vaccine development.

The Vaccine & ISV Congress has enjoyed an exciting history covering all aspects of vaccines since 2007. In 2014, we were privileged to hear from Dr Nancy J Sullivan from the National Institutes of Health Vaccine Research Center on developing a novel Ebola vaccine. We are excited to be holding the 9th Vaccine & ISV Congress in Seoul, Korea and invite you to join us to discuss the following topics:

The conference will include:

Register Now Submit Abstract View Program
Conference Chairs
  • Margaret Liu, ProTherImmune, USA
  • Joon Haeng Rhee, Chonnam National University, South Korea
  • Ted Ross, University of Georgia, USA
Scientific Committee
  • Lulu Bravo, National Institutes of Health, Philippines
  • Alejandro Chabalgoity, University of Uruguay, Uruguay
  • Mandeep Singh Dhingra, Shantha Biotechnics Limited, India
  • Denise Doolan, Queensland Institute of Medical Research, Australia
  • Natalie Garçon, Bioaster Technology Research Institute, France
  • Yiwu He, Bill & Melinda Gates Foundation, USA
  • David Ho, Rockefeller University, USA
  • Ken Ishii, University of Osaka, Japan
  • Jerome Kim, International Vaccine Instiute, South Korea
  • Clarisa B Palatnik de Sousa, University Federal do Rio de Janeiro, Brazil
  • Arthorn Riewpaiboon, Mahidol University, Thailand
  • Bin Wang, Fudan University, China
  • Heather Wilson, University of Saskatchewan, Canada
Organised by
 
  • Elsevier
  • ISV
Sponsors
 
Elsevier

Supporting Journal
Join the Conversation